Pharmaceutical Executive September 11, 2024
Michael Wong

A Harvard Business School Healthcare Alumni Association Q&A with Jeremy Goldberg of Arsenal Capital Partners.

Jeremy Goldberg is an Operating Partner of Arsenal Capital Partners (which has greater than $10 billion AUM), a private equity fund where he focuses on networking and sourcing transactions for the healthcare team. He also serves as a Senior Advisor to $75 billion AUM (TPG) Sixth Street Partners and on several private company board of directors

Goldberg has over 25 years of experience, mainly focused on investing and business development in the pharmaceutical and healthcare industries. Goldberg served as Managing Director, Corporate Development for Endo Pharmaceuticals (Nasdaq: ENDP), a leading pain therapeutics company.

Goldberg has served on the Visiting Committees at Dana Farber Cancer Institute...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Trends
AI models show numerous applications and benefits for radiology
Your Questions, Answered
Q&A: NCPA Announces Independent Community Pharmacy Consortium for Government Engagement
Being Selective and Prudent with AI Could Make 2025 NextGen’s Best
CHOP Focused on Leveraging AI to ‘Transformational’ Effect, Says Chief Digital & Information Officer Shakeeb Akhter

Share This Article